Gene Therapy Drug Product Formulation Scientist

Eurofins; Boston (MA); On-site; USD 44,000 - 56,000; Full time

Benefits offered by this job

Medical, dental, vision insurance

401(k) with company match

Paid vacation and holidays

Bonus potential

Job summary

Eurofins is seeking a Drug Product and Formulation Scientist to work onsite in Boston, MA, supporting LVV-based gene therapy drug product development. You will design bench-scale experiments, document results, and collaborate with process development, analytical development, and operations teams to advance formulation workstreams.

The role emphasizes hands-on formulation optimization, GMP-ready tech transfer, and regulatory documentation, with a clear path toward independent ownership of

Qualifications

• B.S. in Pharmaceutical Science, Chemical Engineering, Chemistry, Biology, Biochemistry or a related field with at least 3 years of relevant industry experience
• Experience with formulation stability studies and/or drug product filtration process development
• Experience supporting technology transfer of GMP-ready formulation methods to manufacturing labs

Responsibilities

• Support formulation and drug product development activities by executing studies to optimize formulation buffer and excipient screening
• Develop and optimize product filtration methods and assess vector recovery
• Enable GMP-compliant drug product manufacturing workflows and scale-up studies
• Maintain accurate GLP-compliant notebooks and data records and draft protocols and technical reports

Skills

Formulation development

GMP familiarity

Documentation

Education

B.S. in Pharmaceutical Science

M.S. in Pharmaceutical Science

Tools

HIAC

FlowCam

NanoFCM

qPCR/ddPCR

Job description

Eurofins is seeking a Drug Product and Formulation Scientist to work onsite in Boston, MA, supporting LVV-based gene therapy drug product development. You will design bench-scale experiments, document results, and collaborate with process development, analytical development, and operations teams to advance formulation workstreams.

The role emphasizes hands-on formulation optimization, GMP-ready tech transfer, and regulatory documentation, with a clear path toward independent ownership of